UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort

Blood, 2008-07, Vol.112 (1), p.141-149

2008

Link zum Volltext

Verfügbarkeit prüfen

How I treat essential thrombocythemia

Blood, 2011-02, Vol.117 (5), p.1472-1482

2011

Link zum Volltext

Verfügbarkeit prüfen

Effects of the JAK2 mutation on the hematopoietic stem and progenitor compartment in human myeloproliferative neoplasms

Blood, 2011-07, Vol.118 (1), p.177-181

2011

Link zum Volltext

Verfügbarkeit prüfen

The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms

Blood, 2010-06, Vol.115 (22), p.4517-4523

2010

Link zum Volltext

Verfügbarkeit prüfen

Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort

Blood, 2012-08, Vol.120 (7), p.1409-1411

2012

Link zum Volltext

Verfügbarkeit prüfen

Comparison of different criteria for the diagnosis of primary myelofibrosis reveals limited clinical utility for measurement of serum lactate dehydrogenase

Haematologica (Roma), 2010-11, Vol.95 (11), p.1960-1963

2010

Link zum Volltext

Verfügbarkeit prüfen

Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia

Blood, 2006-10, Vol.108 (7), p.2435-2437

2006

Link zum Volltext

Verfügbarkeit prüfen

Molecular mechanisms associated with leukemic transformation of MPL-mutant myeloproliferative neoplasms

Haematologica (Roma), 2010-12, Vol.95 (12), p.2153-2156

2010

Link zum Volltext

Verfügbarkeit prüfen

Increased basal intracellular signaling patterns do not correlate with JAK2 genotype in human myeloproliferative neoplasms

Blood, 2011-08, Vol.118 (6), p.1610-1621

2011

Link zum Volltext

Verfügbarkeit prüfen

Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis

Blood, 2005-01, Vol.105 (1), p.324-334

2005

Link zum Volltext

Verfügbarkeit prüfen

Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia

Blood, 2003-08, Vol.102 (4), p.1160-1168

2003

Link zum Volltext

Verfügbarkeit prüfen

Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia

Blood, 2001-09, Vol.98 (6), p.1732-1738

2001

Link zum Volltext

Verfügbarkeit prüfen

Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders

Haematologica (Roma), 2008-11, Vol.93 (11), p.1635-1644

2008

Link zum Volltext

Verfügbarkeit prüfen

Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions

Blood, 2003-09, Vol.102 (6), p.2205-2212

2003

Link zum Volltext

Verfügbarkeit prüfen

Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis

Blood, 2003-11, Vol.102 (10), p.3569-3574

2003

Link zum Volltext

Verfügbarkeit prüfen

SOCS3 tyrosine phosphorylation as a potential bio-marker for myeloproliferative neoplasms associated with mutant JAK2 kinases

Haematologica (Roma), 2009-04, Vol.94 (4), p.576-580

2009

Link zum Volltext

Verfügbarkeit prüfen

Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability

Blood, 2002-06, Vol.99 (12), p.4547-4553

2002

Link zum Volltext

Verfügbarkeit prüfen

Genotype-Phenotype Interactions in the Myeloproliferative Neoplasms: Non-CML Myeloproliferative Diseases

Hematology/oncology clinics of North America, 2012, Vol.26 (5)

2012

Link zum Volltext

Verfügbarkeit prüfen

The SCL Gene: From Case Report to Critical Hematopoietic Regulator

Blood, 1999-05, Vol.93 (9), p.2760-2770

1999

Link zum Volltext

Verfügbarkeit prüfen

JAK2 617V>F-positive polycythemia rubra vera maintained by approximately 18 stochastic stem-cell divisions per year, explaining age of onset by a single rate-limiting mutation. Commentary

Blood, 2007, Vol.110 (5)

2007

Link zum Volltext

Verfügbarkeit prüfen

Bone marrow pathology in essential thrombocythemia : interobserver reliability and utility for identifying disease subtypes. Commentary

Blood, 2008, Vol.111 (1)

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

KollektionOvid SocietyJournals and Single Titles

ThemaLeukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(30)
Hematologic And Hematopoietic Diseases
(30)
Medical Sciences
(30)
Humans
(26)
Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Hematology
(23)
Female
(15)
Middle Aged
(13)
Male
(12)
Adult
(9)
Aged
(9)
Chromosome Deletion
(9)
Myeloproliferative Disorders - Genetics
(9)
Immunology
(8)
Janus Kinase 2 - Genetics
(8)
Polycythemia Vera - Genetics
(8)
Biochemistry
(7)
Cell Biology
(7)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(27)
EZB Electronic Journals Library
(27)
Publisher site
(26)
Ingenta
(4)
Elsevier ScienceDirect Journals Complete
(4)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(3)
LWW Total
(0)

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(22)
Haematologica
(4)
Cancer Genetics And Cytogenetics
(2)
Cancer Genet Cytogenet
(1)
Genomics
(1)
Hematology/oncology Clinics Of North America
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort

How I treat essential thrombocythemia

Effects of the JAK2 mutation on the hematopoietic stem and progenitor compartment in human myeloproliferative neoplasms

The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms

Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort

Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations

Comparison of different criteria for the diagnosis of primary myelofibrosis reveals limited clinical utility for measurement of serum lactate dehydrogenase

Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia

Molecular mechanisms associated with leukemic transformation of MPL-mutant myeloproliferative neoplasms

Increased basal intracellular signaling patterns do not correlate with JAK2 genotype in human myeloproliferative neoplasms

V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis

Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis

Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia

Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia

Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders

Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions

Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis

SOCS3 tyrosine phosphorylation as a potential bio-marker for myeloproliferative neoplasms associated with mutant JAK2 kinases

Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability

Randomized comparison of low-dose versus high-dose interferon-alfa in chronic myeloid leukemia: prospective collaboration of 3 joint trials by the MRC and HOVON groups

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation

Genotype-Phenotype Interactions in the Myeloproliferative Neoplasms: Non-CML Myeloproliferative Diseases

The SCL Gene: From Case Report to Critical Hematopoietic Regulator

JAK2 617V>F-positive polycythemia rubra vera maintained by approximately 18 stochastic stem-cell divisions per year, explaining age of onset by a single rate-limiting mutation. Commentary

Bone marrow pathology in essential thrombocythemia : interobserver reliability and utility for identifying disease subtypes. Commentary

Aktive Filter

Suchergebnisse filtern